112 related articles for article (PubMed ID: 24906288)
41. [Stem cells therapy in amyotrophic lateral sclerosis treatment. A critical view].
Soler B; Fadic R; von Bernhardi R
Rev Neurol; 2011 Apr; 52(7):426-34. PubMed ID: 21425112
[TBL] [Abstract][Full Text] [Related]
42. Human amnion-derived mesenchymal stem cells alleviate lung injury induced by white smoke inhalation in rats.
Cui P; Xin H; Yao Y; Xiao S; Zhu F; Gong Z; Tang Z; Zhan Q; Qin W; Lai Y; Li X; Tong Y; Xia Z
Stem Cell Res Ther; 2018 Apr; 9(1):101. PubMed ID: 29650044
[TBL] [Abstract][Full Text] [Related]
43. Potential Therapeutic Features of Human Amniotic Mesenchymal Stem Cells in Multiple Sclerosis: Immunomodulation, Inflammation Suppression, Angiogenesis Promotion, Oxidative Stress Inhibition, Neurogenesis Induction, MMPs Regulation, and Remyelination Stimulation.
Abbasi-Kangevari M; Ghamari SH; Safaeinejad F; Bahrami S; Niknejad H
Front Immunol; 2019; 10():238. PubMed ID: 30842772
[TBL] [Abstract][Full Text] [Related]
44. Therapeutic benefit of Muse cells in a mouse model of amyotrophic lateral sclerosis.
Yamashita T; Kushida Y; Wakao S; Tadokoro K; Nomura E; Omote Y; Takemoto M; Hishikawa N; Ohta Y; Dezawa M; Abe K
Sci Rep; 2020 Oct; 10(1):17102. PubMed ID: 33051552
[TBL] [Abstract][Full Text] [Related]
45. Stem cell transplantation into the intraventricular space via an Ommaya reservoir in a patient with amyotrophic lateral sclerosis.
Baek W; Kim YS; Koh SH; Lim SW; Kim HY; Yi HJ; Kim H
J Neurosurg Sci; 2012 Sep; 56(3):261-3. PubMed ID: 22854595
[TBL] [Abstract][Full Text] [Related]
46. Anti-aging Effect of Transplanted Amniotic Membrane Mesenchymal Stem Cells in a Premature Aging Model of Bmi-1 Deficiency.
Xie C; Jin J; Lv X; Tao J; Wang R; Miao D
Sci Rep; 2015 Sep; 5():13975. PubMed ID: 26370922
[TBL] [Abstract][Full Text] [Related]
47. Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis.
Hajivalili M; Pourgholi F; Kafil HS; Jadidi-Niaragh F; Yousefi M
Curr Stem Cell Res Ther; 2016; 11(1):41-50. PubMed ID: 26329483
[TBL] [Abstract][Full Text] [Related]
48. Advances, Challenges, and Perspectives in Translational Stem Cell Therapy for Amyotrophic Lateral Sclerosis.
Abati E; Bresolin N; Comi G; Corti S
Mol Neurobiol; 2019 Oct; 56(10):6703-6715. PubMed ID: 30911936
[TBL] [Abstract][Full Text] [Related]
49. Cellular transplants in amyotrophic lateral sclerosis patients: an observational study.
Gamez J; Carmona F; Raguer N; Ferrer-Sancho J; Martín-Henao GA; Martí-Beltrán S; Badia M; Gratacós M; Rodriguez-Gónzalez E; Seoane JL; Pallero-Castillo M; Burgos R; Puiggros C; Pasarin A; Bori-Fortuny I
Cytotherapy; 2010 Sep; 12(5):669-77. PubMed ID: 20586670
[TBL] [Abstract][Full Text] [Related]
50. Human Amniotic Mesenchymal Stem Cells Promote Endogenous Bone Regeneration.
Li J; Zhou Z; Wen J; Jiang F; Xia Y
Front Endocrinol (Lausanne); 2020; 11():543623. PubMed ID: 33133012
[TBL] [Abstract][Full Text] [Related]
51. The Use of Autologous Mesenchymal Stem Cells for Cell Therapy of Patients with Amyotrophic Lateral Sclerosis in Belarus.
Rushkevich YN; Kosmacheva SM; Zabrodets GV; Ignatenko SI; Goncharova NV; Severin IN; Likhachev SA; Potapnev MP
Bull Exp Biol Med; 2015 Aug; 159(4):576-81. PubMed ID: 26395626
[TBL] [Abstract][Full Text] [Related]
52. Preclinical studies of mesenchymal stem cells transplantation in amyotrophic lateral sclerosis: a systemic review and metaanalysis.
Zhou Q; Yuan M; Qiu W; Cao W; Xu R
Neurol Sci; 2021 Sep; 42(9):3637-3646. PubMed ID: 33433755
[TBL] [Abstract][Full Text] [Related]
53. [In vivo tracing of human amniotic mesenchymal stem cells labeled with PKH26 in rat intrauterine adhesions model].
Yang Y; Mao Y; Wang J; Sun C; Zhang Y; Chen X
Sheng Wu Gong Cheng Xue Bao; 2018 Oct; 34(10):1660-1667. PubMed ID: 30394033
[TBL] [Abstract][Full Text] [Related]
54. Therapeutic effects and mechanism of human amnion-derived mesenchymal stem cells on hypercoagulability in a uremic calciphylaxis patient.
Bian A; Ye X; Wang J; Zeng M; Liu J; Liu K; Ning S; Cui Y; Tang S; Xu X; Yuan Y; Su Z; Lu Y; Zhou J; Ma X; Yang G; Huang Y; Chen F; Yu Y; Gu M; Lv X; Wang L; Zhao J; Wang X; Liang N; Xing C; Qin L; Wang N
Ren Fail; 2023 Dec; 45(1):2218483. PubMed ID: 37293809
[TBL] [Abstract][Full Text] [Related]
55. Label-Free Quantitative Proteome Profiling of Cerebrospinal Fluid from a Rat Stroke Model with Stem Cell Therapy.
Hur JW; Kim MS; Oh SY; Kang HY; Bae J; Kim H; Lee H; Lee SW; Park DH
Cell Transplant; 2021; 30():9636897211023474. PubMed ID: 34176333
[TBL] [Abstract][Full Text] [Related]
56. Long-term survival of a patient with amyotrophic lateral sclerosis (ALS) who received autologous adipose-derived mesenchymal stem cells.
Shigematsu K; Takeda T; Komori N; Urushihata N; Oki K; Tahara K; Yamagishi H
Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4086-4090. PubMed ID: 34156687
[TBL] [Abstract][Full Text] [Related]
57. Mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in amyotrophic lateral sclerosis.
Connick P; Chandran S
Cytotherapy; 2014 Aug; 16(8):1031-2. PubMed ID: 24998167
[No Abstract] [Full Text] [Related]
58. [Therapeutic use of amniotic membranes and their derivate cells].
Sapin V; Souteyrand G; Bonnin N; Gallot D; Blanchon L; Chiambaretta F
Gynecol Obstet Fertil; 2011 Jun; 39(6):388-90. PubMed ID: 21612966
[TBL] [Abstract][Full Text] [Related]
59. Mesenchymal stromal cells to halt the progression of type 1 diabetes?
Carlsson PO; Korsgren O; Le Blanc K
Curr Diab Rep; 2015 Jul; 15(7):46. PubMed ID: 26003192
[TBL] [Abstract][Full Text] [Related]
60. Amnion-derived stem cell transplantation: A novel treatment for neurological disorders.
Carvajal HG; Suárez-Meade P; Borlongan CV
Brain Circ; 2016; 2(1):1-7. PubMed ID: 30276271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
